InPoint Commercial Real Estate Income (ICRP) EBITDA Margin Growth (1y) (2018 - 2024)
Powered by 
Analysis
InPoint Commercial Real Estate Income (ICRP) EBITDA Margin Growth (1y) (2018 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.58 Bn | 43.58 Bn | 4.68 Bn | -78.00 |
| 2 | Royalty Pharma | 26.90 Bn | 26.06 Bn | - | -1,651.00 |
| 3 | Royal Gold | 22.28 Bn | 22.10 Bn | 390.45 Mn | -552.00 |
| 4 | OR Royalties | 6.97 Bn | 6.90 Bn | 82.22 Mn | 819.00 |
| 5 | Encore Capital | 2.11 Bn | 1.92 Bn | 455.04 Mn | 391.00 |
| 6 | Atlanticus Holdings | 1.41 Bn | 855.87 Mn | 686.46 Mn | 55.00 |
| 7 | Jefferson Capital | 1.20 Bn | 1.18 Bn | - | -1,087.00 |
| 8 | Upbound | 1.07 Bn | 962.28 Mn | 594.84 Mn | -136.00 |
| 9 | Lufax Holding | 1.05 Bn | -1.58 Bn | - | -1,647.00 |
| 10 | InPoint Commercial Real Estate Income | 56.94 Mn | -2.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -357.00 |
| Sep 30, 2024 | 1,606.00 |
| Jun 30, 2024 | 29,348.00 |
| Dec 31, 2023 | 10,010.00 |
| Sep 30, 2023 | 4,576.00 |
| Jun 30, 2023 | -11,154.00 |
| Dec 31, 2018 | -881.00 |
| Sep 30, 2018 | 9,502.00 |